PODCAST
Pee on a Stick, Save Your Bones, and Sleep Apnea's Hidden Threat
September 8, 2026·11:11·Episode 119
Quick Summary
This episode digs into three research items published this week: a case-based look at daily at-home urine hormone monitoring, an early-stage drug that may improve bone structure and cholesterol after menopause, and a review linking sleep apnea during perimenopause to measurable cognitive decline. Nykki breaks down what the evidence actually shows, what's still speculative, and where each of these is worth paying attention to right now.
Pee on a Stick, Save Your Bones, and Sleep Apnea's Hidden Threat
0:000:00
Key Takeaways
- ✦At-home daily urine hormone monitoring can track patterns over time that a single blood draw misses — but the research is still case-based, meaning we don't yet have large trials proving it changes health outcomes.
- ✦CADD522 is an experimental drug (not available to patients) that showed improvements in bone structure and cholesterol in animal studies of post-menopausal bone loss — it's early, but the mechanism is genuinely novel.
- ✦Sleep apnea in perimenopausal women is underdiagnosed partly because women present differently than men — less snoring, more insomnia and fatigue — and doctors aren't always looking for it.
- ✦The research connecting sleep apnea to cognitive decline in perimenopausal women is observational, meaning it shows a link, not a proven cause — but the link is strong enough to take seriously.
- ✦If you're having significant sleep disruption, mood changes, or brain fog during perimenopause, sleep apnea is worth raising with your doctor — it's treatable and often missed.
Sources & References
Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.